Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human 

Slides:



Advertisements
Similar presentations
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Advertisements

M. M. J. Caron, P. J. Emans, M. M. E. Coolsen, L. Voss, D. A. M
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes  T. Fujisawa, Ph.D., D.D.S.,
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC- derived chondrocytes  R.S. Rainbow, H. Kwon, A.T. Foote, R.C. Preda, D.L.
Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage  A.-C. Bay-Jensen,
Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling  T.-L. Tsai, P.A. Manner,
Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation  Y. Chen, J. Ke, X. Long,
L. Pesesse, C. Sanchez, D. A. Walsh, J. -P. Delcour, C. Baudouin, P
Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway.
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Combination of ADMSCs and chondrocytes reduces hypertrophy and improves the functional properties of osteoarthritic cartilage  M.R. Ahmed, A. Mehmood,
M. M. J. Caron, P. J. Emans, M. M. E. Coolsen, L. Voss, D. A. M
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Z. Zhang, Y. Kang, Z. Zhang, H. Zhang, X. Duan, J. Liu, X. Li, W. Liao 
Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner  A. Bianchi, M. Guibert, F. Cailotto,
Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low- density lipoprotein receptor-1 system in pathogenesis and progression.
TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes  R. Narcisi, L. Signorile,
Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7  M.M.J. Caron, P.J.
X. Zhang, I. Prasadam, W. Fang, R. Crawford, Y. Xiao 
Loss of Vhl in cartilage accelerated the progression of age-associated and surgically induced murine osteoarthritis  T. Weng, Y. Xie, L. Yi, J. Huang,
Chondroprotective effect of the bioactive peptide prolyl-hydroxyproline in mouse articular cartilage in vitro and in vivo  S. Nakatani, H. Mano, C. Sampei,
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Restriction of spontaneous and prednisolone-induced leptin production to dedifferentiated state in human hip OA chondrocytes: role of Smad1 and β-catenin.
Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation  D. Correa, R.A. Somoza, P. Lin, S. Greenberg,
Endoplasmic reticulum stress-induced apoptosis contributes to articular cartilage degeneration via C/EBP homologous protein  Y. Uehara, J. Hirose, S.
Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell- engineered tissue constructs  M. Pei, F. He, B.M. Boyce, V.L.
MicroRNAs of rat articular cartilage at different developmental stages identified by Solexa sequencing  J. Sun, N. Zhong, Q. Li, Z. Min, W. Zhao, Q. Sun,
Chondroprotective effect of the bioactive peptide prolyl-hydroxyproline in mouse articular cartilage in vitro and in vivo  S. Nakatani, H. Mano, C. Sampei,
MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1β-induced chondrocyte responses  F. Meng, Z. Zhang, W.
Depletion of primary cilia in articular chondrocytes results in reduced Gli3 repressor to activator ratio, increased Hedgehog signaling, and symptoms.
P. -J. Francin, A. Abot, C. Guillaume, D. Moulin, A. Bianchi, P
CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGFβ and BMP through SMAD signaling  B. Saitta,
N. Brandl, A. Zemann, I. Kaupe, S. Marlovits, P. Huettinger, H
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Different doses of strontium ranelate and mechanical vibration modulate distinct responses in the articular cartilage of ovariectomized rats  A.G.H. Mierzwa,
H.H. Lee, M.J. O'Malley, N.A. Friel, C.R. Chu 
Differential response of porcine osteoblasts and chondrocytes in cell or tissue culture after 5-aminolevulinic acid-based photodynamic therapy  J.D. Bastian,
PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage  S. Otsuka, M.D., T. Aoyama, M.D., Ph.D.,
Reduced chondrocyte proliferation, earlier cell cycle exit and increased apoptosis in neuronal nitric oxide synthase-deficient mice  Q. Yan, Q. Feng,
Attenuation of subchondral bone abnormal changes in osteoarthritis by inhibition of SDF-1 signaling  Y. Chen, S. Lin, Y. Sun, J. Guo, Y. Lu, C.W. Suen,
V. Queirolo, D. Galli, E. Masselli, R. M. Borzì, S. Martini, F
Suppression of Sestrins in aging and osteoarthritic cartilage: dysfunction of an important stress defense mechanism  T. Shen, O. Alvarez-Garcia, Y. Li,
Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that.
M.M.-G. Sun, F. Beier  Osteoarthritis and Cartilage 
T. Kimura, T. Ozaki, K. Fujita, A. Yamashita, M. Morioka, K. Ozono, N
Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell- engineered tissue constructs  M. Pei, F. He, B.M. Boyce, V.L.
The extent of degeneration of cruciate ligament is associated with chondrogenic differentiation in patients with osteoarthritis of the knee  K. Kumagai,
Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet 
Exercise intervention increases expression of bone morphogenetic proteins and prevents the progression of cartilage-subchondral bone lesions in a post-traumatic.
Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins  M. Pei, M.D., Ph.D., J. Luo, M.D.,
M. M. J. Caron, P. J. Emans, M. M. E. Coolsen, L. Voss, D. A. M
Lentiviral vector-mediated shRNAs targeting a functional isoform of the leptin receptor (Ob-Rb) inhibit cartilage degeneration in a rat model of osteoarthritis 
Volume 23, Issue 8, Pages (August 2015)
Synergistic effects of growth and differentiation factor-5 (GDF-5) and insulin on expanded chondrocytes in a 3-D environment  B. Appel, J. Baumer, D.
Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications 
Z. Lin, M. B. , N. J. Pavlos, B. Sc. (Hons. ), Ph. D. , M. A. Cake, B
Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis  M. Bellido, L. Lugo,
Growth characterization of neo porcine cartilage pellets and their use in an interactive culture model  Carsten Lübke, Ph.D., Jochen Ringe, M.Sc., Veit.
Intra-articular injection of interleukin-4 decreases nitric oxide production by chondrocytes and ameliorates subsequent destruction of cartilage in instability-induced.
Cartilaginous repair of full-thickness articular cartilage defects is induced by the intermittent activation of PTH/PTHrP signaling  S. Kudo, H. Mizuta,
Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage  F. Wei, J. Zhou, X. Wei,
Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation  Y. Akasaki, M.D., S. Matsuda,
J.L. Huebner, J.M. Williams, M. Deberg, Y. Henrotin, V.B. Kraus 
Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis 
Insulin decreases autophagy and leads to cartilage degradation
Y. Akasaki, A. Hasegawa, M. Saito, H. Asahara, Y. Iwamoto, M.K. Lotz 
Inhibition of miR-449a Promotes Cartilage Regeneration and Prevents Progression of Osteoarthritis in In Vivo Rat Models  Dawoon Baek, Kyoung-Mi Lee, Ki.
Presentation transcript:

Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human  A. Filip, A. Pinzano, A. Bianchi, B. Fève, S. Jalkanen, P. Gillet, D. Mainard, P. Lacolley, J. Magdalou, N. Mercier  Osteoarthritis and Cartilage  Volume 24, Issue 7, Pages 1223-1234 (July 2016) DOI: 10.1016/j.joca.2016.01.340 Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Expression of SSAO in cartilage of normal rat. (A) Histological examination of cross section of Wistar rat knee joint stained with HES (morphology), safranin O (proteoglycan content), and immunostained with the anti-SSAO antibody. Only one representative picture is shown. Arrows indicate anti-SSAO immunostaining. The micrographs were taken at a magnification of 10× (subchondral bone and cartilage zone) and 40× (cartilage zone); the scale bars represent 200 μm. (B) SSAO immunostained of growth plate cartilage with a magnification of 10× and 40×. The scale bars represent 200 μm. (C) SSAO mRNA expression in articular cartilage and in positive controls (adipose tissue and aorta) from three rats. RPS29 mRNA expression was used for normalization. Results are expressed as fold change relative to aorta. (D) SSAO enzyme activity in articular cartilage, adipose tissue and aorta was expressed in nmol/h/mg. All results are presented as the mean value ± 95% CI of three different experiments, each performed in duplicate for real time qPCR and enzyme activity assay. All comparisons are made vs aorta values. Osteoarthritis and Cartilage 2016 24, 1223-1234DOI: (10.1016/j.joca.2016.01.340) Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Expression of differentiation-dependent markers in primary cultures of rat chondrocytes. Rat chondrocytes were cultured from confluence (day 0) until day 21 in a differentiation medium. Terminal differentiation of chondrocytes was monitored at day 7, 14 and 21. (A) Representative photographs of chondrocytes in culture during the differentiation protocol. The micrographs were taken at magnification of 10×; the scale bar represents 200 μm. In these conditions, mRNA expression of chondrogenic markers: Sox 9 (B), collagen II (C), aggrecan (D) and mRNA expression of pre-hypertrophic collagen X (E) and hypertrophic markers MMP13 (F) and ALP (G) were quantified. RPS29 mRNA expression was used for standardization, and results are expressed as relative expression to day 0 expression according to delta delta Ct method. In graphs, dots represent the average of duplicate for a single cell culture. The lines show the average values ± 95% CI of three to four different cell cultures. Comparisons are made vs day 0 values. Osteoarthritis and Cartilage 2016 24, 1223-1234DOI: (10.1016/j.joca.2016.01.340) Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 Differentiation dependent expression and activity of SSAO in primary cultures of rat chondrocytes. (A) SSAO mRNA expression was evaluated by RT-qPCR. (B) SSAO protein expression was analyzed by western blotting in two different cell cultures. Immunoblot intensities for SSAO/Tubulin were quantified by densitometry. Intensities at days 0 were set at 1. A representative result is shown. (C) Enzyme activity was measured in parallel, and expressed in nmol/h/mg. In A and C graphs, dots represent means of duplicates and lines, the average value ± 95% CI of four to five different cell cultures. All comparisons are made vs day 0 values. Osteoarthritis and Cartilage 2016 24, 1223-1234DOI: (10.1016/j.joca.2016.01.340) Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 Chondrocyte viability and glucose transport. Chondrocytes were treated (gray triangles) or not (open circles) from confluence (day 0) with 1 μM LJP 1586, as a selective SSAO inhibitor. (A) Cell viability was determined by MTT reduction at days 0, 7, 14 and 21. Results are expressed as the difference between A560 and A620 nm the mean of four different cell cultures ± 95% CI. (B) Glucose transport was estimated by the entrance rate of 2-DG in chondrocyte, cultured 21 days after confluence as indicated in Methods. Lines indicate the mean ± 95% CI of five distinct cell cultures. Statistics were calculated with respect to control cells. When indicated, the brackets under P values indicate that LJP-treated values were compared vs control values of the corresponding time point. Osteoarthritis and Cartilage 2016 24, 1223-1234DOI: (10.1016/j.joca.2016.01.340) Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 Effect of SSAO activity inhibition during the course of rat chondrocyte terminal differentiation. Chondrocytes were treated (black bars) or not (gray bars) from confluence (day 0) with 1 μM LJP 1586, as a selective SSAO inhibitor. (A) The SSAO enzyme activity expressed in nmol/h/mg was performed to confirm the efficacy of LJP 1586 in one experiment done in duplicate. The expression of SSAO (B), MMP13 hypertrophic marker (C), ALP (D) and OPN (E) mineralization markers and Collagen X pre-hypertrophic marker (F), were monitored by the determination of mRNA levels expressed as fold change relative to day 0, at days 7, 14 and 21, SSAO mRNA expression at days 7, 14 and 21, relative to day 0. Dots stent for one single cell culture performed in duplicate and lines represent the average value ± 95% CI of five to six different cell cultures. Statistics were calculated with respect to the day 0. The brackets under P values indicate that values from LJP-treated cells were compared vs control ones of the corresponding time point. Osteoarthritis and Cartilage 2016 24, 1223-1234DOI: (10.1016/j.joca.2016.01.340) Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 Expression of SSAO in human OA cartilage. The OA cartilage samples were obtained from knee joints of five patients. For each patient, a zone of preserved (Mankin score 2–4) or damaged cartilage (Mankin score 4 to 13) were taken for histology, SSAO activity and mRNA expression. (A) less affected or (B) damaged Human cartilage examination with HES (morphology), safranin O (proteoglycan content) staining and immunohistochemical analysis using anti-type X collagen and anti-SSAO antibodies. Representative micrographs of one patient were shown at a magnification of 10×, 20× and 40×. The scale bars represent 200 μm. SSAO enzyme activity in nmol/h/mg (C) and expression of collagen X (D), MMP13 (E), and OPN (F) mRNA in 2–4 Mankin score zone (open circles) and 4–13 Mankin score zone (gray triangles) cartilage were measured in five patients which means ± 95% CI are symbolized by lines. Results (D–F) are expressed as the relative expression of mRNA to the 2–4 score zone of each patient. Osteoarthritis and Cartilage 2016 24, 1223-1234DOI: (10.1016/j.joca.2016.01.340) Copyright © 2016 Osteoarthritis Research Society International Terms and Conditions